DPT Laboratories

DPT Laboratories Overview

Year Founded: 1990

Number of Employees: 1,000

Key Personnel: Paul Johnson, President; Paul Josephs, Vice President Sales & Marketing;
Lyle Flom, Vice President, Development & Commercial Services

Who We Are
DPT, a DFB Pharmaceuticals, Inc. company, is a contract development and manufacturing organization (CDMO). DPT provides pharmaceutical, biotechnology, and consumer healthcare companies the best solutions to their drug development and manufacturing needs through innovation, technology, and service. Specializing in semi-solid and liquid dosage forms, DPT has a reputation for quality, unmatched technical expertise, extensive sterile and non-sterile manufacturing capabilities, and an exemplary regulatory compliance record.

Customers choose DPT as a strategic partner because of our ability to provide fully integrated drug development and manufacturing solutions. DPT customers have confidence that their projects, from concept to commercial manufacturing, will be handled by professionals with unparalleled knowledge and experience, using state-of-the-art equipment and processes.

The ability to develop, manufacture, and commercialize products in semi-solid and liquid dose forms makes DPT unique. To get your next product to market fast and with confidence, call DPT – The Industry Source for Semi-solids and Liquids®.

Comprehensive Drug Development Services for Sterile & Non-sterile Dose Forms
• Pre-formulation and formulation development
• Biopharmaceutical development
• Analytical method development and validation
• Stability studies
• Process development and validation
• Pilot and proof-of-concept batches from 0.3 kg
• Clinical trial materials phase I-III

Packaging Services
• Identification and sourcing of relevant packaging options
• Packaging specification development
• Formulation and package compatibility assessment
• Packaging equipment sourcing, design, and engineering services
• Turnkey sourcing services for unique and specialized packaging

Manufacturing Services for Sterile and Non-sterile Dose Forms
• Four cGMP facilities
• cGMP batch sizes from 0.3 kg - 25,000 kg
• Controlled substances Schedules II-V
• Extensive packaging capabilities for semi-solids and liquids
• Specialized equipment installation, operational qualification, and validation services
• Sterile manufacturing for pilot, clinical, and commercial scale
• Sterile batch sizes from <500 mL to 50 liters
• pMDI and aerosol manufacturing capabilities

Facilities
Headquartered in San Antonio, TX, DPT has four facilities there and one in Lakewood, NJ, with state-of-the-art development, manufacturing, packaging, and distribution space.